Literature DB >> 17030229

Selection of patients for aspirin desensitization treatment.

Donald D Stevenson1, Ronald A Simon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030229     DOI: 10.1016/j.jaci.2006.06.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  23 in total

1.  A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.

Authors:  Geneva A DeGregorio; Joseph Singer; Katherine N Cahill; Tanya Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2018-11-02

Review 2.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

3.  Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease.

Authors:  Elina Jerschow; Matthew L Edin; Teresa Pelletier; Waleed M Abuzeid; Nadeem A Akbar; Marc Gibber; Marvin Fried; Fred B Lih; Artiom Gruzdev; J Alyce Bradbury; Weiguo Han; Golda Hudes; Taha Keskin; Victor L Schuster; Simon Spivack; Darryl C Zeldin; David Rosenstreich
Journal:  J Allergy Clin Immunol Pract       Date:  2017-01-31

Review 4.  Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.

Authors:  Joshua M Levy; Luke Rudmik; Anju T Peters; Sarah K Wise; Brian W Rotenberg; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-02       Impact factor: 3.858

5.  [Adaptive desensitization for acetylsalicylic acid hypersensitivity: A success story?].

Authors:  G Mühlmeier; R Hausch; H Maier
Journal:  HNO       Date:  2015-10       Impact factor: 1.284

6.  Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps.

Authors:  Sonya Marcus; Joseph Schertzer; Lauren T Roland; Sarah K Wise; Joshua M Levy; John M DelGaudio
Journal:  Int Forum Allergy Rhinol       Date:  2019-10-10       Impact factor: 3.858

Review 7.  Clinical immunology review series: an approach to desensitization.

Authors:  M T Krishna; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

Review 8.  Factors driving the aspirin exacerbated respiratory disease phenotype.

Authors:  John W Steinke; Larry Borish
Journal:  Am J Rhinol Allergy       Date:  2015 Jan-Feb       Impact factor: 2.467

Review 9.  Aspirin hypersensitivity and desensitization protocols: implications for cardiac patients.

Authors:  Phil Lambrakis; Gordon F Rushworth; Jane Adamson; Stephen J Leslie
Journal:  Ther Adv Drug Saf       Date:  2011-12

Review 10.  Aspirin sensitivity and desensitization for asthma and sinusitis.

Authors:  Donald D Stevenson
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.